Microba Life Sciences Limited
ASX:MAP.AX
0.165 (AUD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||||
Net Income
| -8.45 | -11.488 | -5.744 | -7.001 | -3.501 | -5.679 | -2.84 | -5.44 | -2.72 | -6.03 | -3.015 | -5.34 | -2.67 | -2.183 | -1.092 |
Depreciation & Amortization
| 1.826 | 1.044 | 0.328 | 0.894 | 0.321 | 0.748 | 0.374 | 0.858 | 0.234 | 0.685 | 0.343 | 0.601 | 0.108 | 0.617 | 0.309 |
Deferred Income Tax
| 0 | -4.409 | 0 | -3.662 | 1.889 | -1.824 | -0.05 | -1.203 | 0.513 | -1.394 | -0.024 | -0.747 | 0.455 | 0 | 0 |
Stock Based Compensation
| 0 | 0.18 | 0.18 | 0.091 | 0.091 | 0.119 | 0.119 | 0.132 | 0.132 | 0.188 | 0.188 | 0.145 | 0.145 | 0.137 | 0.137 |
Change In Working Capital
| 2.525 | -1.533 | -1.605 | -2.407 | -2.196 | 0.788 | 0.118 | -0.768 | -0.768 | 0.072 | 0.072 | -0.887 | -0.887 | 0 | 0 |
Accounts Receivables
| 3.399 | -3.409 | -1.705 | -3.878 | -1.939 | 0.064 | 0.032 | -0.683 | -0.683 | -0.204 | -0.204 | -0.514 | -0.514 | 0 | 0 |
Change In Inventory
| -0.187 | -0.124 | -0.062 | -0.082 | -0.041 | -0.202 | -0.101 | 0.038 | 0.038 | 0.039 | 0.039 | -0.086 | -0.086 | 0 | 0 |
Change In Accounts Payables
| -1.184 | 1.393 | 0 | 2.177 | 0 | -0.071 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| 0.496 | 0.607 | 0.161 | -0.629 | -0.215 | 0.996 | 0.187 | -0.123 | -0.123 | 0.236 | 0.236 | -0.287 | -0.287 | 0 | 0 |
Other Non Cash Items
| 1.732 | 4.63 | 1.054 | 3.726 | 1.104 | 1.814 | 0.211 | -0.357 | -0.206 | 2.922 | 0.516 | 0.997 | 0.832 | 0.563 | -0.472 |
Operating Cash Flow
| -3.992 | -11.575 | -5.787 | -8.359 | -4.18 | -4.034 | -2.017 | -6.655 | -3.328 | -3.794 | -1.897 | -4.944 | -2.472 | -2.237 | -1.119 |
Investing Activities: | |||||||||||||||
Investments In Property Plant And Equipment
| -2.66 | -1.719 | -0.086 | -1.534 | -0.162 | -1.503 | -0.114 | -1.7 | -0.791 | -0.173 | -0.027 | -0.369 | -0.082 | -0.303 | -0.042 |
Acquisitions Net
| 0 | -9.57 | -4.785 | 0 | 0 | 0 | 0 | 0 | 0 | 0.009 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.204 | 0 | -0.204 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0 | -0.774 | -0.774 | -0.605 | -0.605 | 0.038 | -0.619 | -0.059 | 0.014 | 0.19 | -0.062 | -0.128 | -0.128 | 0.15 | -0.035 |
Investing Cash Flow
| -2.66 | -11.29 | -5.645 | -1.534 | -0.767 | -1.465 | -0.732 | -1.554 | -0.777 | -0.178 | -0.089 | -0.369 | -0.21 | -0.153 | -0.077 |
Financing Activities: | |||||||||||||||
Debt Repayment
| -0.301 | -0.241 | 0 | -0.22 | 0 | -0.225 | 0 | -0.272 | 0 | -0.071 | 0 | -0.072 | 0 | -0.07 | 0 |
Common Stock Issued
| 0 | 19.099 | 0 | 0 | 0 | 17.238 | 0 | 28.095 | 0 | 1.25 | 0 | 6.231 | 0 | 7.963 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| -0.441 | 9.267 | 9.267 | -0.035 | -0.035 | 8.377 | 8.377 | 14.07 | 14.07 | 0.538 | 0.538 | 3.018 | 3.018 | 3.9 | 3.9 |
Financing Cash Flow
| -0.14 | 18.534 | 9.267 | -0.069 | -0.035 | 16.754 | 8.377 | 28.14 | 14.07 | 1.076 | 0.538 | 6.035 | 3.018 | 7.8 | 3.9 |
Other Information: | |||||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0.066 | 0.066 | 0.026 | 0.026 | 0.059 | 0.059 | 0.284 | 0.284 | 13.029 | 0 | 0 | -12.643 | 6.897 | 0 |
Net Change In Cash
| -6.957 | -4.198 | -2.099 | -9.91 | -46.909 | 11.169 | 5.687 | 20.652 | 10.249 | -2.896 | -1.448 | 0.722 | -12.307 | 12.307 | 2.705 |
Cash At End Of Period
| 20.889 | 27.846 | -2.099 | 32.044 | -4.955 | 41.954 | 5.687 | 30.785 | 20.382 | 10.133 | -1.448 | 13.029 | 0 | 12.307 | 2.705 |